Insider Transactions in Q4 2021 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2021
|
Jeffrey Bluestone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+50.0%
|
-
|
|
Nov 10
2021
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-2.24%
|
$58,290
$67.32 P/Share
|
|
Nov 10
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,913
+4.69%
|
-
|
|
Nov 10
2021
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,320
-12.1%
|
$155,440
$67.32 P/Share
|
|
Nov 10
2021
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,100
+21.0%
|
-
|
|
Oct 22
2021
|
Anthony Welters Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,368
+50.0%
|
-
|